A detailed history of Ever Source Wealth Advisors, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 95 shares of PRTA stock, worth $1,445. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Previous 95 -0.0%
Holding current value
$1,445
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$19.54 - $26.15 $19 - $26
1 Added 1.06%
95 $1,000
Q1 2024

Jun 11, 2024

BUY
$24.75 - $40.66 $24 - $40
1 Added 1.08%
94 $2,000
Q4 2023

Feb 09, 2024

BUY
$32.31 - $52.32 $2,100 - $3,400
65 Added 232.14%
93 $3,000
Q3 2023

Nov 03, 2023

SELL
$47.3 - $70.6 $13,291 - $19,838
-281 Reduced 90.94%
28 $1,000
Q2 2023

Aug 04, 2023

BUY
$48.26 - $78.59 $14,912 - $24,284
309 New
309 $21,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.